Tin tức thị trường chứng khoán

J&J Phase 1b/2 OrigAMI-4: Subcutaneous Amivantamab Shows 42% ORR In Head & Neck Cancer

Johnson & Johnson's amivantamab showed promising results with a 42% ORR in heavily pretreated head and neck cancer, but further …

"Well-Funded" NGO Machine Behind Newark Anti-ICE Chaos; Bessent Signals Nonprofit Crackdown

The panel discusses potential impacts of IRS guidance on nonprofits tied to activism, with risks including capital flight, reputational damage, …

2 Space Stocks to Buy Before the SpaceX IPO on June 12

The panel consensus is bearish on AST SpaceMobile (ASTS) and Intuitive Machines (LUNR), citing significant execution risks, uncertain revenue visibility, …

Den Beste Kryptovaluta å Kjøpe Med $1 000 Akkurat Nå

The Best Cryptocurrency to Buy With $1,000 Right Now

The panel is divided on Solana's investment merit, with concerns about repeated outages, unclear ETF timeline, and intense competition from …

Nvidia Recently Plowed $3.8 Billion Into These 2 Artificial Intelligence (AI) Stocks

Despite strategic positioning in AI infrastructure, Nvidia's investments in CoreWeave and Coherent pose significant risks, including high leverage, potential dilution, …

Social Security Work Rules You Must Understand Before Working in Retirement

The panel generally agreed that while working in retirement can potentially increase Social Security benefits, the current system presents significant …

Pfizer's BRAFTOVI Combo Nearly Doubles PFS In BRAF V600E Metastatic Colorectal Cancer

Pfizer's BREAKWATER Cohort 3 data shows promising results in first-line BRAF V600E mCRC, with a significant PFS benefit and encouraging …

Eli Lilly's Retevmo Phase 3 LIBRETTO-432 Cuts Recurrence Risk 83% In RET+ Early-Stage NSCLC

Eli Lilly's selpercatinib (Retevmo) showed promising results in a Phase 3 trial, reducing recurrence risk by 83% in early-stage RET-positive …

A Rare Buying Opportunity May Be Here With This Top Stock

Despite strong fundamentals like 75% recurring revenue and 17% procedure growth, the panel is cautious due to high valuation (51x …

SoundHound AI's Stock Price Is Down 29% in the Last 6 Months -- Here's Why It Still Could Be a Long-Term Buy

The panel consensus is bearish on SoundHound's planned acquisition of LivePerson, citing immediate dilution, unproven synergies, high integration risk, and …

This AI Hardware Bottleneck Is Determining the Next Trillion-Dollar Tech Companies

The panel generally agrees that while AI is driving demand for memory, the cyclical nature of the industry and potential …

Bốn trên 10 người gặp khó khăn khi truy cập tín hiệu di động khi di chuyển ở Vương quốc Anh

Four in 10 struggle to access mobile signal on the move in the UK

The UK's mobile connectivity issues stem from uneven rollout favoring urban areas and congestion in city centers. While government initiatives …